DO [Medicine]: Ohio University, Athens, OH; 2009
Internship [Internal Medicine]: University of South Florida, Tampa, FL; 2009-2010
Residency [Internal Medicine]: The Ohio State University Wexner Medical Center, Columbus, OH; 2010 - 2012
Fellowship [Hematology-Oncology]: University of Arizona Cancer Center, Tucson, AZ; 2012 - 2015
Working with the Bezos Family Immunotherapy Clinic medical director, Dr. David Maloney, Dr. Acharya is focused on enhancing the understanding and management of chimeric antigen receptor (CAR) T-cell therapy-related toxicity. His research interests also include expanding the utility of cellular therapies to additional disease states as well as standardizing clinical management of patients treated with CAR-T cells. His particular disease-focused research interest is in developing novel therapies to optimize clinical outcomes for patients with acute myeloid leukemia.
Dr. Acharya is board certified by the American Board of Medical Specialties in internal medicine, hematology, and medical oncology. He was on faculty at The Ohio State University prior to joining the Fred Hutchinson Cancer Research Center and treats patients with leukemia, lymphoma, and myelodysplastic syndrome. He has clinical expertise in CAR T-cell therapy and serves as an attending physician at the SCCA Bezos Family Immunotherapy Clinic and on the inpatient Immunotherapy Service at the UW Medical Center.